What is the minimum order quantity?

The minimum order quantity is 2000 pieces.

What are the lead times for production?

Peak season lead time is one month, while off-season lead time is within 15 workdays.

Henan Origin 100ml Florfenicol 45% Injection for Veterinary Use

Name: Henan Origin 100ml Florfenicol 45% Injection for Veterinary Use
Brand: Henan Chuangxin Biological Technology Co., Ltd.
SKU: 2271021895

Henan, ChinaHenan Chuangxin Biological Technology Co., Ltd.

US$2.00

1,000 bottle

Sample price:US$88.00/bottle2000480265.Request sample

Product profile

Customization

Available

Varieties

Growth Promoting Medicine

Component

Chemical Synthetic Drugs

Model NO.

FLORFENICOL 45% Injection

Type

The First Class

Pharmacodynamic Influential Factors

Repeated Medication

Storage Method

Light Proof

Veterinary Reg. No.

(2023) Veterinary Drug Production Certificate No.(

Transport Package

Carton

Specification

100ml

Trademark

CXBT

Origin

Henan, China

Key features

High Concentration Formula: 450 mg/mL concentration reduces injection volume for efficient large animal dosing.

Broad-Spectrum Antibiotic: Effective against key respiratory pathogens like Mannheimia haemolytica and Streptococcus suis.

GMP Certified Production: Manufactured in a GMP standard model factory with 8 automated production lines.

Sterile Formulation: Colorless to slightly yellow clear solution ensuring safety and purity.

Flexible Customization: Offers full, minor, and flexible customization from samples or designs.

Multiple Packaging Options: Available in 100 mL, 250 mL, 500 mL bottles to suit various needs.

Strict Quality Inspection: 100% visual and function inspection for all finished products.

Established Manufacturer: Henan Chuangxin Biological Technology Co., Ltd. with 5 years of export experience.

Company profile

Self-brandedPatents AwardedFlexible CustomizationQuality Assurance

Henan Chuangxin Biological Technology Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5years CertifiedNearest Port: Shanghai Port, Shenzhen PortAverage Response Time: ≤3.78h

AI-Powered supplier vetting

SummaryHenan Chuangxin Biological Technology Co., Ltd. is a China-based manufacturing company in animal pharmaceuticals, with stated research, production, sales, and after-sales activities. Evidence shows multiple specialized facilities, in-stock capacity, export activity, documented finished-product inspection, and broad customization, ODM, and OEM capabilities. However, the supplier reports no new products in the past year, no 3D software design, no quality-control test equipment, no valid manufacturing-capacity contract with related subcontractors, and limited documentation for some service-management procedures. The provided information does not establish certifications, specific customer cases, or sufficient financial credibility.

Supplier typeThe supplier is identified as a factory and a combined company in Henan, China, operating in health and medicine and chemicals. Its stated business integrates animal-drug R&D, manufacturing, sales, and after-sales service, with products including ivermectin, veterinary medicine, and enrofloxacin injection.

After-Sales capabilityThe company explicitly describes after-sales service as part of its operations, and technology engineers provide technical support for production and after-sales service. Customer complaints have a clear procedure with followed records, although the broader effective-service assessment and corrective-action process lack records.

R&D capabilityThe supplier has five R&D engineers whose responsibilities include confirming requirements, designing products, and providing technical support, and it offers ODM services. Nevertheless, it reports no new products in the past year, no 3D software design services, and no available SDK, indicating limitations in documented recent innovation and digital design capability.

Production capacityThe supplier reports formulating, filling, sterile, feeding, mixture, and packing facilities, a 6,605.0 m² manufacturing plant, in-stock capacity, and uniformly followed finished-product inspection instructions. Production-related weaknesses include zero quality-control test equipment reported and no valid contract with related subcontractors for manufacturing capacity.

Customization capabilityThe supplier explicitly offers customization from samples and designs, full, minor, and flexible customization, as well as ODM and OEM services for popular brands. This is direct evidence of broad customization capability, despite the separate lack of 3D software design services.